Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?-Reference-Cited by-同舟云学术

Ritonavir-boosted antiretroviral therapy precipitating tacrolimus toxicity in a renal transplant patient: is it time for a priori tacrolimus dosage reduction?

Published:2021-10-01 Issue:12 Volume:35 Page:2065-2068
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Naccarato Mark,Kwee Francine,Zaltzman Jeffrey,Fong Ignatius W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference18 articles.

1. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity;Bentata;Artif Organs,2020

2. Induction effects of ritonavir: implications for drug interactions;Foisy;Ann Pharmacother,2008

3. Drug interaction after ritonavir discontinuation: considerations for antiretroviral therapy changes in renal transplant recipients;Jimenez;Int J STD AIDS,2019

4. Three renal failure cases successfully treated with ombitasvir/paritaprevir/ritonavir for genotype 1b hepatitis C virus reinfection after liver transplantation;Orita;Clin J Gastroenterol,2019

5. Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient;Miceli;Bone Marrow Transplant,2012

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus;Frontiers in Pharmacology;2024-06-19

2. Optimizing the use of nirmatrelvir/ritonavir in solid organ transplant recipients with COVID-19: A review of immunosuppressant adjustment strategies;Frontiers in Immunology;2023-04-04

3. Ritonavir/tacrolimus interaction;Reactions Weekly;2021-12